Phase 3 Allergic Clinical Trials
18 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–18 of 18 trials
Recruiting
Phase 3
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Perennial Allergic Rhinitis (PAR)
Eli Lilly and Company450 enrolled77 locationsNCT06339008
Recruiting
Phase 3
A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)
Allergic Asthma
Bridgette Jones300 enrolled1 locationNCT04699604
Recruiting
Phase 3
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
Allergic RhinitisAllergic Rhinoconjunctivitis
ALK-Abelló A/S300 enrolled30 locationsNCT07060885
Recruiting
Phase 2Phase 3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Skin InflammationAllergic Contact Dermatitis
Wei-Che Ko45 enrolled1 locationNCT05535738
Recruiting
Phase 3
Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma
Perennial Allergic Rhinitis Accompanied by Asthma
Daewon Pharmaceutical Co., Ltd.274 enrolled1 locationNCT07168473
Recruiting
Phase 3
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Allergic Rhinitis, Seasonal
Genrix (Shanghai) Biopharmaceutical Co., Ltd.150 enrolled1 locationNCT07154342
Recruiting
Phase 3
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.150 enrolled32 locationsNCT04435990
Recruiting
Phase 3
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled27 locationsNCT04898283
Recruiting
Phase 3
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled32 locationsNCT04891237
Recruiting
Phase 2Phase 3
Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Shanghai Mabgeek Biotech.Co.Ltd160 enrolled1 locationNCT06846385
Recruiting
Phase 3
Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine
Allergic Rhinitis
Laboratorios Silanes S.A. de C.V.70 enrolled1 locationNCT06916884
Recruiting
Phase 3
A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
Allergic Bronchopulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh300 enrolled1 locationNCT06174922
Recruiting
Phase 2Phase 3
Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT
Allergic Rhinitis Due to Grass Pollen
Lars Olaf Cardell360 enrolled3 locationsNCT06061848
Recruiting
Phase 3
The response of the eye to different ocular allergy eyedrops
Perennial allergic conjunctivitisSeasonal allergic conjunctivitis
The University of New South Wales90 enrolled1 locationACTRN12623001119684
Completed
Phase 2Phase 3
Omalizumab for Chronic Allergic Bronchopulmonary Aspergillosis: a randomised, placebo-controlled crossover trial
Allergic Bronchopulmonary Aspergillosis
Jo Douglass14 enrolled1 locationACTRN12613000278730
Recruiting
Phase 3
Safety and Tolerability of a nasal spray in patients with Chronic allergic or nonallergic rhinitis
chronic allergic or nonallergic rhinitis
MedPointe Pharmaceuticals800 enrolled1 locationACTRN12606000348550
Completed
Phase 3Phase 4
DOES USE OF INHALED FLUTICASONE PRIOR TO AN ADENOSINE 5'MONOPHOSPHATE (AMP) BRONCHIAL PROVOCATION TEST AFFECT THE PERCEPTION OF DYSPNOEA?
AsthmaAllergic Rhinitis
Woolcock Institute of Medical Research12 enrolled1 locationACTRN12605000611628
Completed
Phase 3
Mannitol and nasal mucociliary clearance
Allergic Rhinitis
Woolcock Institute of Medical Research36 enrolled1 locationACTRN12605000473662